Cash & equivalents decreased 84.2%
Cash & equivalents changed -84.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$51.5M→$8.2M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SPRY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital decreased 36.1%
Working capital changed -36.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$235.8M→$150.6M4 prior comparisons
Free-cash-flow proxy decreased 53.7%
Free-cash-flow proxy changed -53.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
-$39.6M→-$60.9M4 prior comparisons
Operating cash flow decreased 53.9%
Operating cash flow changed -53.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
-$39.6M→-$60.9M4 prior comparisons
Operating income decreased 29.1%
Operating income changed -29.1% from the comparable as-filed period.
-$47.6M→-$61.5M3 prior comparisons
Net income decreased 38.9%
Net income changed -38.9% from the comparable as-filed period.
-$44.9M→-$62.3M3 prior comparisons
Operating margin moved 12033 bp higher
Operating margin changed +12033 basis points from the comparable as-filed period.
-302.95%→-182.62%3 prior comparisons
Revenue increased 114.2%
Revenue changed +114.2% from the comparable as-filed period.
$15.7M→$33.7M3 prior comparisons
Working capital / assets moved 1485 bp lower
Working capital / assets changed -1485 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
75.23%→60.38%4 prior comparisons
Current liabilities increased 33.5%
Current liabilities changed +33.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$45.6M→$60.9M4 prior comparisons
Inventory / revenue moved 4938 bp lower
Inventory / revenue changed -4938 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
140.69%→91.31%2 prior comparisons
Inventory increased 39.0%
Inventory changed +39.0% from the comparable as-filed period.
$22.1M→$30.7M2 prior comparisons
Selling, general & administrative increased 42.8%
Selling, general & administrative changed +42.8% from the comparable as-filed period.
$54.3M→$77.6M3 prior comparisons
Stock-based compensation increased 130.8%
Stock-based compensation changed +130.8% from the comparable as-filed period.
$5.4M→$12.4M3 prior comparisons
Trade receivables increased 86.4%
Trade receivables changed +86.4% from the comparable as-filed period.
$25.1M→$46.8M2 prior comparisons
Current assets decreased 24.8%
Current assets changed -24.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$281.4M→$211.5M4 prior comparisons
Research & development increased 16.4%
Research & development changed +16.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$4.0M→$4.7M3 prior comparisons
Receivables / revenue moved 2070 bp lower
Receivables / revenue changed -2070 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
159.87%→139.16%2 prior comparisons
Total assets decreased 20.4%
Total assets changed -20.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$313.5M→$249.5M4 prior comparisons
SBC / revenue moved 265 bp higher
SBC / revenue changed +265 basis points from the comparable as-filed period.
34.17%→36.83%3 prior comparisons
Capital expenditure decreased 100.0%
Capital expenditure changed -100.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$51,000→$04 prior comparisons
Current ratio decreased 43.7%
Current ratio changed -43.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
6.17→3.484 prior comparisons
R&D / revenue moved 1171 bp lower
R&D / revenue changed -1171 basis points from the comparable as-filed period.
25.67%→13.96%3 prior comparisons
Free-cash-flow margin moved 7121 bp higher
Free-cash-flow margin changed +7121 basis points from the comparable as-filed period.
-252.23%→-181.02%3 prior comparisons
Operating cash-flow margin moved 7089 bp higher
Operating cash-flow margin changed +7089 basis points from the comparable as-filed period.
-251.91%→-181.02%3 prior comparisons
Capex / revenue moved 32 bp lower
Capex / revenue changed -32 basis points from the comparable as-filed period.
0.32%→0.00%3 prior comparisons
Shares outstanding increased 0.6%
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 7 prior comparable changes.
98,826,337→99,447,3437 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.